Biomarkers Associated With Spontaneous Preterm Birth Less Than 32 Wks Gestation
Non-Invasive Sampling of Inflammatory Mediators Associated With Spontaneous Preterm Birth Less Than 32 Weeks Gestation
1 other identifier
observational
24
1 country
1
Brief Summary
Preterm delivery (PTD) is a leading cause of neonatal mortality and continues to be a major public health concern, reaching 12.9% in 2006, despite intense research to reverse this trend. Currently, fetal fibronectin (fFN) screening and cervical length determined by ultrasound are two tests which are proven to have benefit in the identification of those at greatest risk for preterm delivery. However the benefit of these tests is limited to situations where a negative result can avoid unnecessary interventions. Currently, maternal fetal monitoring is limited, as it is difficult to "see" what is going on in the placenta (maternal-fetal interface) without invasive measures such as placental biopsy or amniocentesis. Our goal for this study is to identify a group of biomarkers in non-invasive compartments (such as saliva, blood, urine, and/or cervical and vaginal secretions) that are associated with preterm labor and birth. We hypothesize that preterm labor will display an inflammatory profile, which consists of unique inflammatory biomarkers from different non-invasive bodily fluid compartments (such as Il-10 in urine, VEGF in cervical secretions, and IP-10 in saliva), that correlates with a high incidence of preterm birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 10, 2014
CompletedFirst Posted
Study publicly available on registry
December 16, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2017
CompletedJanuary 29, 2018
January 1, 2018
3 years
December 10, 2014
January 25, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Gestational age at delivery
Within 5 months of Preterm labor
Study Arms (1)
Preterm labor group
Patients who are admitted for evaluation of preterm labor.
Eligibility Criteria
Pregnant females between the age of 18-40 who present in preterm labor will be asked to participate.
You may qualify if:
- Pregnant women age 18-40 years old between 20 to 32 weeks gestation with singleton pregnancies and are admitted to Winthrop University Hospital for evaluation of preterm labor. Preterm labor will be defined as contractions every 5 minutes associated with cervical changes or cervical dilatation \> 2cm with 80% effacement. Subjects must have reliable dates confirmed by early ultrasound.
You may not qualify if:
- Indicated preterm births (i.e. pre-eclampsia), multiple pregnancies, known major fetal abnormality (ex. those that are known to be incompatible with life) and premature rupture of membranes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Winthrop University Hosptial
Mineola, New York, 11501, United States
Biospecimen
1. Saliva - We will collect saliva in a sterile container. 2. Maternal Blood - Blood samples will be collected during routine blood draws and into serum separator tubes, spun, and the serum stored at -80°C. 3. Urine - Urine samples will be collected into a sterile container. 4. Cervical and vaginal secretions - During speculum exam, we will simultaneously insert two Weck-Cell Sponges directly into the cervical os for collection of cervical secretions then another two sponges will be applied in the posterior fornix for collection of vaginal fluid.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
RANJITH KAMITY, MD
Winthrop University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 10, 2014
First Posted
December 16, 2014
Study Start
January 1, 2013
Primary Completion
January 2, 2016
Study Completion
September 7, 2017
Last Updated
January 29, 2018
Record last verified: 2018-01